May 30, 2018
3-4 p.m. ET
NCATS will jointly host a webinar about NIH’s small business funding and applicant support programs on May 30, 2018. Sponsored in part by NCATS, the National Cancer Institute’s (NCI) Small Business Innovation Research (SBIR) Development Center and the Women’s Business Development Center (WBDC), the webinar will focus on NIH’s SBIR and Small Business Technology Transfer funding programs, NCI and NCATS resources, free applicant assistance programs as well as a variety of WBDC programs, such as the Invent Illinois Program. Lili Portilla, NCATS’ director of strategic alliances is one of the panelists.
May 30-31, 2018
Two NCATS staff members are featured speakers at the 2018 Lab Automation virtual event. Nathan P. Coussens, Ph.D., senior research scientist, will present “Inhibitors of NSD2 Discovered by High-Throughput Screening with a Nucleosome Substrate” at 10:30 a.m. PT on May 30, 2018. Sam Michael, Ph.D., director of automation and compound management, will deliver a keynote address on “NCATS Automation Capabilities ― Where We Are and Where We Are Going” at 7:30 a.m. PT on May 31, 2018.
Event participants will discuss instrumentation and methodology advances that increase the efficiency and effectiveness of research in the laboratory. Other key topics include high-throughput screening, robotics, data management in the age of big data, and organs-on-chips.
June 2, 2018
8 a.m. to 3 p.m. ET
University of Rochester
Saunders Research Building
265 Crittenden Boulevard
Rochester, New York 14642
Hosted by the Center for Leading Innovation and Collaboration (CLIC), which is supported by NCATS through its Clinical and Translational Science Awards (CTSA) Program, this meeting will bring together researchers, clinicians, policymakers, public health professionals, health care innovators, opinion leaders and others to discuss and develop innovative approaches to address the opioid crisis through translational science. This “un-meeting” will not have a traditional meeting structure; rather, the participants will create and drive the agenda and discussions. The event will foster new collaborative teams and networks to generate ideas that can advance research to reduce the misuse and abuse of opioids, while exploring innovative approaches to improve outcomes for those affected by this epidemic.
Aug. 20-21, 2018
National Institutes of Health (Main Campus)
NIH Clinical Center (Bldg. 10), Masur Auditorium
10 Center Drive
Bethesda, Maryland 20892
NCATS and the Food and Drug Administration’s Center for Biologics Evaluation and Research are co-sponsoring a workshop to review the state of current gene therapy approaches, identify challenges and strategies to overcome them, and discuss how to collaboratively scale and accelerate gene therapy development to benefit patients with rare diseases for which there is no effective treatment.
Proposed panel sessions will focus on (1) pre-clinical development, (2) clinical innovation, (3) manufacturing, (4) partnerships and transitions, (5) business models and patient access, and (6) gene therapy as a precision medicine tool.
There is no admission fee to attend, and the workshop also will be videocast at https://videocast.nih.gov.